PPTA's 2012 Plasma Protein Forum

Over 300 patients, policymakers and industry representatives convened in Washington, DC on June 21-22 for the 2012 Plasma Protein Forum. The conference centered on the theme of rare diseases.

Highlights of the 2012 Forum:

Myrl Weinberg, President of the National Health Council delivered a dynamic keynote assessing risk and benefit from a patient perspective.

	The Honorable Michael C. Burgess, (R-TX), outlined health policy perspectives from the U.S. Congress. Other presentations and panels addressed the impact of the Affordable Health Care Act on the States, the cost effectiveness of plasma protein therapies.

PPTA staff welcomes attendees to the Forum	Kym Kilbourne, Congressman Michael Burgess and Jan M. Bult

Josh Penrod presents Rudolf Meixner, President, Europlasma GmbH with IQPP certification -- the first in the Czech Republic	Ileana Carlisle delivers a testament to industry in final act as Source Board Chair

Exhibitors demonstrate the latest industry innovations	Attendees enjoy informal opportunities to connect

Steve Pettaway received the Otto Schwarz Award for leadership in the industry and scientific fields of expertise	Otto Schwarz Award accepted by Christopher Healey, Grifols

Created on June 22 2012.

Media and Information

PPTA News

Monkeypox Virus and Plasma Protein Therapies +

PPTA considers that the current MPXV outbreak is not a concern for the safety margins of plasma protein therapies manufactured by PPTA member companies. This assessment is also shared by other concerned parties (AABB, WHO).

Since May 2022, Monkeypox virus (MPXV) infections have been reported in non-endemic countries across Europe and North America (WHO, CDC, ECDC). People who use plasma protein therapies are understandably concerned about whether their therapies remain safe, with respect to MPXV. To address this issue, PPTA has summarized currently available facts.
Read More
Announcing PPTA’s New Global Chair +

It is with great pleasure that the Plasma Protein Therapeutics Association (PPTA) announces the election of Giles Platford from Takeda to the Chair of the PPTA Global Board.
Read More
Public Review until August 31: Proposed Confirmation of IQPP Standard for Recording Donor Adverse Events +
The following proposed actions are hereby opened for public review:
- Confirmation (continued implementation) of Version 2.0 of the IQPP Standard for Recording Donor Adverse Events
Resulting from a scheduled review by the PPTA IQPP Standards Committee and discussion by the PPTA Global Plasma Board of Directors, it was agreed that this document should be “confirmed.” In other words, it was agreed that the document should continue to be implemented as part of the IQPP Standards Program, without change. Members of the public are invited to comment on this proposed action. The text of the standards themselves is not being considered for revision at this time.
Read More
PPTA's 2021 Annual Report Now Available +

On March 16, PPTA published its 2021 Annual Report, providing an overview of the Association’s activities throughout the year. This year’s digital report offers readers an engaging and interactive experience as they read about PPTA’s work on behalf of its global membership and in support of patients who rely on plasma-derived therapies. We invite you to read the report here.
Read More

1
2
3

› ‹

The Source, the international magazine of the plasma protein therapeutics industry, is published three times a year.

Learn more about the need for plasma donors, plasma donation, and how you can save and improve lives.
Find a Donation Center.

The need for plasma and plasma donors is more urgent than ever before. Visit givingplasma.org to learn more and to find a donation center near you.

"How Is Your Day?" is an initiative to raise awareness of the unique nature of plasma protein therapies and the value they provide to patients. It aims to inform and educate decision makers and the general public worldwide.

Get involved and follow "How Is Your Day?" on social media @HIYDglobal

Media and Information

Advocacy

Copyright © 2022 PPTA. All rights reserved. (202) 789-3100

Terms of Use | Privacy Statement | Sitemap